Antibody-drug conjugates (ADCs) were the highlight of this year’s annual meeting of the American Society of Clinical Oncology, sparking excitement…
Browsing: drugmakers
One way Astellas is doing this is through collaborations with other companies to create what Zieler calls “modalities of the…
The pharmaceutical industry is facing uncertainty due to the looming threat of tariffs. While the Trump administration initially exempted pharmaceuticals…
Overall, the repercussions of the FDA workforce reductions are becoming increasingly evident in the pharmaceutical industry. As companies face delays…
The freeze on communications from federal health agencies following President Donald Trump’s second inauguration has had far-reaching implications for the…
” As the government and industry work to increase transparency in drug pricing, the ultimate goal is to empower patients…
By leveraging their internal expertise, pharma companies can identify promising assets and make more informed decisions about which companies to…
The impending split between Veeva and Salesforce, longtime partners in the life sciences software industry, is causing a stir among…
As the generic drug market braces for higher costs and potential shortages, the recent imposition of a 10% tariff on…
Avian Influenza: The Threat of Bird Flu and the Preparedness for a Potential Outbreak An H5N1 outbreak is currently wreaking…
